BioCryst hits another hurdle, delays trial for its 1 remaining clinical candidate

cafead

Administrator
Staff member
  • cafead   Feb 24, 2023 at 09:12: AM
via Just a few months after discontinuing its most advanced pipeline asset, BioCryst Pharmaceuticals is now delaying testing of its only remaining clinical candidate.

article source
 

<